A new collaboration between BetterSeeds and Caszyme aims to bypass one of the most persistent constraints in plant gene editing: tissue culture. By combining ultra‑compact Cas12l nucleases with engineered plant viral vectors, the partners say they can deliver precise gene edits directly into crops, cutting time, cost and genotype dependency while making CRISPR more accessible to seed companies
Read more here.